Proteomics for Biomarker Discovery in Acute Kidney Injury

Seminars in Nephrology

Volumn 27, Issue 6, 2007, Pages 637-651

  Devarajan, Prasad ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Acute renal failure; biomarker panel; cystatin C; interleukin 18; kidney injury molecule 1; neutrophil gelatinase associated lipocalin; proteomics

Indexed keywords

3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID; ALPHA 1 MICROGLOBULIN; CASPASE 8; CASPASE 9; CYSTATIN C; CYTOCHROME C; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FETUIN; FETUIN A; INTERLEUKIN 18; LIPOCALIN; MEPRIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ARTICLE; CREATININE BLOOD LEVEL; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; HUMAN; IMMUNOREACTIVITY; KIDNEY INJURY; KIDNEY TUBULE CELL; LIVER TRANSPLANTATION; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; ROC CURVE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINARY TRACT INFECTION;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; KIDNEY FAILURE, ACUTE; LIPOCALINS; MEMBRANE GLYCOPROTEINS; PROTEOMICS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 36549025838     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2007.09.005     Document Type: Article

References (129)

1. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11 (2007) R31
2. Lameire N., Van Biesen W., and Vanholder R. Acute renal failure. Lancet 365 (2005) 417-430
3. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294 (2005) 813-818
4. Palevsky P.M. Epidemiology of acute renal failure: the tip of the iceberg. Clin J Am Soc Nephrol 1 (2006) 6-7
5. Liangos O., Wald R., O'Bell J.W., et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 1 (2006) 43-51
6. Xue J.L., Daniels F., Star R.A., et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17 (2006) 1135-1142
7. Ympa Y.P., Sakr Y., Reinhart K., et al. Has mortality from acute renal failure decreased?. A systematic review of the literature. Am J Med 118 (2005) 827-832
8. Waikar S.S., Curhan G.C., Wald R., et al. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 17 (2006) 1143-1150
9. Metnitz P.G., Krenn C.G., Steltzer H., et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30 (2002) 2051-2058
10. Clermont G., Acker C.G., Angus D.C., et al. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62 (2002) 986-996
11. Lassning A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15 (2004) 1597-1605
12. Levy M.M., Macias W.L., Vincent J.L., et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33 (2005) 2194-2201
13. Chertow G.M., Burdick E., Honour M., et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005) 3365-3370
14. Hoste E.A.J., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury is associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 10 (2006) R73-R82
15. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17 (2006) 1503-1520
16. Schrier R.W. Need to intervene in established acute renal failure. J Am Soc Nephrol 15 (2004) 2756-2758
17. Hewitt S.M., Dear J., and Star R.A. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 15 (2004) 1677-1689
18. Herget-Rosenthal S., Marggraf G., Hüsing J., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 66 (2004) 1115-1122
19. Bellomo R., Kellum J.A., and Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 30 (2004) 33-37
20. Allgren R.L., Marbury T.C., Rahman S.N., et al. Anaritide in acute tubule necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336 (1997) 828-834
21. Hirschberg R., Kopple J., Lipsett P., et al. Multicenter clinical trial of recombinant human insulin-like growth factor 1 in patients with acute renal failure. Kidney Int 55 (1999) 2423-2432
22. Devarajan P., Mishra J., Supavekin S., et al. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 80 (2003) 365-376
23. Han W.K., and Bonventre J.V. Biologic markers for the early detection of acute kidney injury. Curr Op Crit Care 10 (2004) 476-482
24. Zhou H., Hewitt S.M., Yuen P.S.T., et al. Acute kidney injury biomarkers-needs, present status, and future promise. NephSAP 5 (2006) 63-71
25. Perco P., Pleban C., Kainz A., et al. Protein biomarkers associated with acute renal failure and chronic kidney disease. Eur J Clin Invest 36 (2006) 753-763
26. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 156 (2007) 203-212
27. Bonventre J.V. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol 156 (2007) 213-219
28. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. Epub 2007 Mar 30, PMID:17394022.
29. American Society of Nephrology. Renal research report. J Am Soc Nephrol 16 (2005) 1886-1893
30. Zerhouni E. The NIH roadmap. Science 302 (2003) 63-65
31. Thongboonkerd V. Proteomics in nephrology: current status and future directions. Am J Nephrol 24 (2004) 360-378
32. Thongboonkerd V. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery. Expert Rev Proteomics 2 (2005) 349-366
33. Vidal B.C., Bonventre J.V., and Hsu S.I.-H. Towards the application of proteomics in renal disease diagnosis. Clin Sci 109 (2005) 421-430
34. Pisitkun T., Johnstone R., and Knepper M.A. Discovery of urinary biomarkers. Mol Cell Proteomics 5 (2006) 1760-1771
35. O'Riordan E., Gross S.S., and Goligorsky M.S. Technology insight: renal proteomics-at the crossroads between promise and problems. Nat Clin Pract Nephrol 2 (2006) 445-458
36. Witzmann F.A., and Li J. Proteomics and nephrotoxicity. Contrib Nephrol 141 (2004) 104-123
37. Gibbs A. Comparison of the specificity and sensitivity of traditional methods for assessment of nephrotoxicity in the rat with metabolomic and proteomic methodologies. J Appl Toxicol 25 (2005) 277-295
38. Schaub S., Wilkins J.A., Rush D., and Nickerson P. Developing a tool for noninvasive monitoring of renal allografts. Expert Rev Proteomics 3 (2006) 497-509
39. Wishart D.S. Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens 15 (2006) 637-642
40. Thongboonkerd V., Klein J.B., Jevans A.W., and McLeish K.R. Urinary proteomics and biomarker discovery for glomerular diseases. Contrib Nephrol 141 (2004) 292-307
41. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 (1993) 561-577
42. In: Pepe M.S. (Ed). The statistical evaluation of medical tests for classification and prediction (2003), Oxford University Press, Cary, NC
43. Pepe M.S., Etzioni R., Feng Z., et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93 (2001) 1054-1061
44. Nguyen M., Ross G., Dent C., et al. Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 25 (2005) 318-326
45. Supavekin S., Zhang W., Kucherlapati R., et al. Differential gene expression following early renal ischemia-reperfusion. Kidney Int 63 (2003) 1714-1724
46. Cheng C.-W., Rifai A., Ka S.-M., et al. Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int 68 (2005) 2694-2703
47. Thakar C.V., Zahedi K., Revelo M.P., et al. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 115 (2005) 3451-3459
48. Yuen P.S.T., Jo S.-K., Holly M.K., et al. Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol Genomics 25 (2006) 375-386
49. Ichimura T., Bonventre J.C., Bailly V., et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273 (1998) 4135-4142
50. Muramatsu Y., Tsujie M., Kohda Y., et al. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 62 (2002) 1601-1610
51. Zahedi K., Wang Z., Barone S., et al. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. Am J Physiol 284 (2003) F1046-F1055
52. Saikumar P., and Venkatachalam M.A. Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 6 (2003) 512-521
53. Kaushal G.P., Basnakian A.G., and Shah S.V. Apoptotic pathways in ischemic acute renal failure. Kidney Int 66 (2004) 500-505
54. Dagher P.C. Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney Int 66 (2004) 506-509
55. Del Rio M., Imam A., DeLeon M., et al. The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia. J Am Soc Nephrol 15 (2004) 41-51
56. Burns A.T., Davies D.R., McLaren A.J., et al. Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation 66 (1998) 872-876
57. Oberbauer R., Rohrmoser M., Regele H., et al. Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10 (1999) 2006-2013
58. Schwarz C., Hauser P., Steininger R., et al. Failure of Bcl-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Lab Invest 82 (2002) 941-948
59. Hoffman S.C., Kampen R.L., Amur S., et al. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 74 (2002) 916-923
60. Castaneda M.P., Swiatecka-Urban A., Mitsnefes M.M., et al. Activation of mitochondrial apoptotic pathways in human renal allografts following ischemia-reperfusion. Transplantation 76 (2003) 50-54
61. Hauser P., Schwarz C., Mitterbauer C., et al. Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 84 (2004) 353-361
62. Ortiz A., Justo P., Sanz A., et al. Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66 (2003) 1589-1594
63. Fleischer A., Ghadiri A., Dessauge F., et al. Modulating apoptosis as a target for effective therapy. Mol Immunol 43 (2006) 1065-1079
64. Faubel S., and Edelstein C.L. Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 5 (2005) 269-287
65. Green D.R., and Kroemer G. Pharmacologic manipulation of cell death: clinical applications insight?. J Clin Invest 115 (2005) 2610-2617
66. Bouchier-Hayes L., Lartigue L., and Newmeyer D.D. Mitochondria: pharmacological manipulation of cell death. J Clin Invest 115 (2005) 2640-2647
67. Letai A. Pharmacologic manipulation of Bcl-2 family members to control cell death. J Clin Invest 115 (2005) 2648-2655
68. Lavrik I.N., Golks A., and Krammer P.H. Caspases: pharmacological manipulation of cell death. J Clin Invest 115 (2005) 2665-2672
69. Jani A., Ljubanivic D., Faubel S.G., et al. Caspase inhibition prevents the increase in caspase-3, -2, -8 and -9 activity and apoptosis in the cold ischemic mouse kidney. Am J Transplant 8 (2004) 1246-1254
70. Hoglen N.C., Chen L.S., Fisher C.D., et al. Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor. J Pharmacol Exp Ther 309 (2004) 634-640
71. Quadri S.M., Segall L., de Perrot M., et al. Caspase inhibition improves ischemia-reperfusion injury after lung transplantation. Am J Transplant 5 (2005) 292-299
72. Mishra J., Ma Q., Prada A., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 4 (2003) 2534-2543
73. Mishra J., Mori K., Ma Q., et al. Neutrophil gelatinase-associated lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24 (2004) 307-315
74. Mori K., Lee H.T., Rapoport D., et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115 (2005) 610-621
75. Schmitt-Ott K.M., Mori K., Kalandadze A., et al. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 15 (2005) 442-449
76. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 365 (2005) 1231-1238
77. Parikh C.R., Mishra J., Thiessen-Philbrook H., et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 70 (2006) 199-203
78. Wagener G., Jan M., Kim M., et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105 (2006) 485-491
79. Mishra J., Ma Q., Kelly C., et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 21 (2006) 856-863
80. Parikh C.R., Jani A., Mishra J., et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 6 (2006) 1639-1645
81. Trachtman H., Christen E., Cnaan A., et al. Urinary neutrophil gelatinase-associated lipocalin in D+HUS: a novel marker of renal injury. Pediatr Nephrol 21 (2005) 989-994
82. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., et al. Neutrophil gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 26 (2006) 287-292
83. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., et al. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography. Nephrol Dial Transplant 22 (2007) 295-296
84. Hirsch R., Dent C., Pfriem H., et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol (2007) Epub ahead of print, PMID: 17874137
85. Zapitelli M., Washburn K.K., Arikan A.A., et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care (2007) 11:R84 Epub ahead of print, PMID: 17678545
86. Mitsnefes M., Kathman T., Mishra J., et al. Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 22 (2007) 101-108
87. Xu S., and Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 482 (2000) 298-307
88. Han W.K., Bailly V., Abichandani R., et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62 (2006) 237-244
89. Ichimura T., Hung C.C., Yang S.A., et al. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol 286 (2004) F552-F563
90. Vaidya V.S., Ramirez V., Ichimura T., et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol 290 (2006) F517-F529
91. Liangos O., Han W.K., Wald R., et al. Urinary kidney injury molecule-1 level is an early and sensitive marker of acute kidney injury following cardiopulmonary bypass. [abstract]. J Am Soc Nephrol 17 (2006) 403A
92. Han W.K., Waikar S.S., Johnson A., et al. Urinary biomarkers for early detection of acute kidney injury. [abstract]. J Am Soc Nephrol 17 (2006) 403A
93. Liangos O., Perianayagam M.C., Vaidya V.S., et al. Urinary N-Acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18 (2007) 904-912
94. Wang Z., Zahedi K., Barone S., et al. Overexpression of SSAT in kidney cells recapitulates various phenotypic aspects of kidney ischemia-reperfusion injury. J Am Soc Nephrol 15 (2004) 1844-1852
95. Tarabishi R., Zahedi K., Mishra J., et al. Induction of Zf9 in the kidney following early ischemia/reperfusion. Kidney Int 68 (2005) 1511-1519
96. Hochegger K, Koppelstatter C, Tagwerker A, et al. p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia reperfusion injury. Am J Physiol Renal Physiol. 2007;292:F762-8.
97. Nath K.A., Dvergsten J., Correa-Rotter R., et al. Induction of clusterin and chronic oxidative renal disease in the rat and its dissociation from cell injury. Lab Invest 71 (2004) 209-218
98. Caron A., Desrosiers R.R., and Beliveau R. Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, β-actin and rho GTPases in proximal tubules. Arch Biochem Biophys 431 (2004) 31-46
99. Akagi R., Takahashi T., and Sassa S. Cytoprotective effects of heme oxygenase in acute renal failure. Contrib Nephrol 148 (2005) 70-85
100. Takahashi T., Itano Y., Noji S., et al. Induction of renal metallothionein in rats with ischemic renal failure. Res Commun Mol Pathol Pharmacol 110 (2001) 147-160
101. Nishiyama J., Kobayashi S., Ishida A., et al. Up-regulation of Galectin-3 in acute renal failure of the rat. Am J Pathol 157 (2000) 815-823
102. Bonventre J.V., Sukhatme V.P., Bamberger M., et al. Localization of the protein product of the immediate early growth response gene, Egr-1, in the kidney after ischemia and reperfusion. Cell Regul 2 (1991) 251-260
103. Briscoe D.M., Pober J.S., Harmon W.E., et al. Expression of vascular cell adhesion molecule-1 in human renal allografts. J Am Soc Nephrol 3 (1992) 1180-1185
104. Witzgall R., Brown D., Schwarz C., et al. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93 (1994) 2175-2188
105. Aufricht C. Heat-shock protein 70: molecular supertool?. Ped Nephrol 20 (2005) 707-713
106. Kielar M.L., John R., Bennett M., et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16 (2005) 3315-3325
107. Gobe G., Zhang Z.J., Wollgoss D.A., et al. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 11 (2000) 454-467
108. Yoshino J., Monkawa T., Tsuji M., Hayashi M., and Saruta T. Leukemia inhibitory factor is involved in tubular regeneration after experimental acute renal failure. J Am Soc Nephrol 14 (2003) 3090-3101
109. du Cheyron D., Daubin C., Poggioli J., et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 42 (2003) 497-506
110. Nadasdy T., Laszik Z., Blick K.E., et al. Human acute tubular necrosis: a lectin and immunohistochemical study. Hum Pathol 26 (1995) 230-239
111. Hortin G.L., and Sviridov D. Diagnostic potential for urinary proteomics. Pharmacogenomics 8 (2007) 237-255
112. Gonzalez-Buitrago J.M., Ferreira L., and Lorenzo I. Urinary proteomics. Clin Chim Acta 375 (2007) 49-56
113. Fliser D., Novak J., Thongboonkerd V., et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 18 (2007) 1057-1071
114. Clarke W., Silverman B.C., Zhang Z., et al. Characterization of renal allograft rejection by urinary proteomic analysis. Anal Surg 237 (2003) 660-664
115. Schaub S., Rush D., Wilkins J., et al. Proteome-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15 (2004) 219-227
116. Schaub S., Wilkins J., Weiler T., et al. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65 (2004) 323-332
117. Nguyen M.T., Ross G.F., Dent C.L., et al. Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 25 (2005) 318-326
118. Lefler D.M., Pafford R.G., Black N.A., et al. Identification of proteins in slow continuous ultrafiltrate by reversed-phase chromatography and proteomics. J Proteome Res 3 (2004) 1254-1260
119. Zhou H., Pisitkun T., Aponte A., et al. Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 70 (2006) 1847-1857
120. Pisitkun T., Shen R.F., and Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101 (2004) 13368-13373
121. Zhou H., Yuen P.S., Pisitkun T., et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 69 (2006) 1471-1476
122. Molls R.M., Savransky V., Liu M., et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol 290 (2006) F1187-F1193
123. Holly M.K., Dear J.W., Hu X., et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int 70 (2006) 496-506
124. Schrier R.W., and Wang W. Acute renal failure and sepsis. N Engl J Med 351 (2004) 159-169
125. Melnikov V.Y., Ecder T., Fantuzzi G., et al. Impaired IL-18 processing protects caspase-1 deficient mice from ischemic acute renal failure. J Clin Invest 107 (2001) 1145-1152
126. Parikh C.R., Jani A., Melnikov V.Y., Faubel S., and Edelstein C.L. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 43 (2004) 405-414
127. Parikh C.R., Abraham E., Ancukiewicz M., et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16 (2005) 3046-3052
128. Herget-Rosenthal S., Poppen D., Husing J., et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 50 (2004) 552-558
129. VandeVoorde R.G., Katman T.I., Ma Q., et al. Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury. [abstract]. J Am Soc Nephrol 17 (2006) 404A